Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,982 public trials 2,028 recruiting studies

Immunoproliferative Disorders trial results

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Lymphocytic Leukaemia, +22 more
Locations
  • Royal Liverpool and Broadgreen University Hospital NHS Trust Liverpool, United Kingdom
  • The Christie NHS Foundation Trust Manchester, United Kingdom
  • The Churchill Hospital Oxford, United Kingdom
  • Derriford Hospital Plymouth, United Kingdom
Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Teva Investigational Site 165 Tucson, Arizona, United States
  • Teva Investigational Site 167 Little Rock, Arkansas, United States
  • Teva Investigational Site 11 Corona, California, United States
  • Teva Investigational Site 21 Fountain Valley, California, United States
View all 128 locations
Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +116 more
Locations
  • Institut Jules Bordet Brussels, Belgium
  • CHU de Grenoble - Hopital de la Tronche Grenoble, France
  • German Hodgkin's Lymphoma Study Group Cologne, Germany
  • Ospedale San Martino Genoa, Italy
Conditions
Adenocarcinoma, Adnexal Diseases, Any T-cell Malignancy, +70 more
Locations
  • Mayo Clinic Arizona - Cancer Clinical Research Unit Scottsdale, Arizona, United States
  • Stanford Cancer Center - Stanford University Stanford, California, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Icahn School of Medicine at Mount Sinai Hess Center for Science and Medicine New York, United States